Our results demonstrate that, in IDH mutant gliomas, (1) the TCA cycle is inhibited, (2) β-oxidation is suppressed, especially in clinical samples due to carnitine deficiency, (3) energy production is reduced, and (4) molecules required for cell division (amino acids and nucleic acids) are reduced. This evidence concerns the gene IDH2 and central nervous system cancer.